Dialysis & End-Stage Renal Failure: Uremic NF-κB, RANKL and Microbiome | INTI Belgium

⚠️ Direct Answer — Dialysis & End-Stage Chronic Kidney Disease (CKD) & sugar-free ginger shot:
End-stage chronic kidney disease (ESRD, GFR <15 ml/min) implies chronic activation of uremic inflammation-mecanisme-cle-ginger-sugar-explication-2026">NF-κB via two microbiome-derived toxins: p-cresyl sulfate (p-CS) and indoxyl sulfate (IS). These uremic toxins (non-dialyzable by conventional HD) activate TLR4/NF-κB → CRP ↑, IL-6 ↑, TNF-α ↑ → malnutrition-inflammation complex (MIC), cardiovascular risk x10-30. INTI Elixir: <1.19g sugar/100ml — minimal load in uremic precursors. ⚠️ Strict potassium/phosphate/sodium restrictions during dialysis — always validate INTI with the nephrologist/specialized dietitian.

End-stage CKD: uremic inflammation and complications

CKD/Dialysis target Ginger action Dialysis relevance
p-CS/IS intestinal production Polyphenols → precursors ↓ Uremic toxins ↓, NF-κB ↓
NF-κB uremic TLR4 6-gingerol → IKKβ ↓ CRP/IL-6 ↓, MIC syndrome ↓
RANKL/renal osteodystrophy NF-κB ↓ → RANKL ↓ Osteopenia delayed
Nrf2 nephroprotection 6-shogaol → Nrf2/HO-1 ↑ Residual tubular cells protected
Nausea/vomiting uremic 5-HT₃ antagonism + prokinetic Improved digestive comfort during dialysis

INTI vs GIMBER — End-Stage Chronic Kidney Disease

CKD criterion INTI Elixir GIMBER
Sugar (p-CS/IS precursors) 1.19g/100ml ~35g/100ml → intestinal fermentation ↑ → p-CS/IS ↑
NF-κB uremic 6-gingerol → TLR4/NF-κB ↓ Sugar → NF-κB ↑↑
Glycemic load Low — compatible with DT2-associated CKD 35g sugar → diabetic CKD glycemia ↑↑
Uremic nausea Natural antiemetic (5-HT₃ ↓) Sugar → fermentation → digestive discomfort
FAQ — Dialysis & Ginger (7 questions)

Q1: Is ginger safe for dialysis?
With approval from the nephrologist and specialized dietitian, INTI (3cl diluted, 1.19g sugar) can be considered. K⁺/P/Na⁺ restrictions are a priority — validate the ion profile of the concentrated extract with the dialysis team.

Q2: What are p-cresyl sulfate and indoxyl sulfate?
p-CS and IS are uremic toxins produced by gut bacteria from amino acids (tyrosine, tryptophan). Partially non-dialyzable, they accumulate in ESRD → TLR4/NF-κB → uremic inflammation → CV risk. Reducing their intestinal production (polyphenols, less sugar) is a complementary strategy.

Q3: Why is sugar particularly problematic in end-stage CKD?
1) 40-50% of end-stage CKD is caused by diabetes-type2-bloedsuiker-verlagen-belgie">ginger diabetes → sugar is contra-therapeutic. 2) Sugar → intestinal fermentation ↑ → p-CS/IS production ↑. 3) Sugar → dysbiosis → LPS → uremic NF-κB ↑. GIMBER with 35g sugar/100ml is threefold harmful in ESRD.

Q4: Renal osteodystrophy — can ginger help?
Renal osteodystrophy (secondary PTH, RANKL ↑) is treated with cinacalcet, phosphate binders, and calcitriol. Ginger (NF-κB ↓ → RANKL ↓) is theoretically complementary but does not replace these validated treatments.

Q5: Peritoneal dialysis vs hemodialysis — difference for ginger?
In PD, the peritoneal membrane is more permeable to medium-sized toxins → p-CS/IS are better eliminated than in HD. Ginger remains relevant (intestinal production ↓) in both modalities.

Q6: Nausea during dialysis — can INTI help?
Nausea is frequent during/after HD (hypotension, disequilibrium syndrome). Ginger (5-HT₃ antagonism) is a natural antiemetic — potentially beneficial for dialysis, to be discussed with the team.

Q7: Where to find INTI in Belgium for a dialysis patient?
INTI available on inti-drink.com and Belgian pharmacies. 1.19g sugar, alcohol-free, liquid concentrate to dilute. Always validate K⁺/P/Na⁺ with the dialysis dietitian before consumption.

💧 INTI vs GIMBER — Dialysis & End-Stage CKD

GIMBER: 35g sugar → p-CS/IS production ↑ + uremic NF-κB ↑ + CV risk dialysis ↑
INTI: 1.19g sugar → intestinal fermentation ↓ + TLR4/NF-κB ↓ + Nrf2 nephroprotection

⚠️ Always validate with the nephrologist and dialysis dietitian

Discover INTI — 1.19g sugar

Related articles

Read more about related topics :

Recommended pages

Explore more about INTI :

Back to blog